Top 10 Players in the Tissue Diagnostics Arena
[Redding California], [20-11-2023] –
Meticulous Research, a renowned market research company, has conducted an
in-depth analysis of the Tissue Diagnostics Market, unveiling the top 10
companies driving the industry. The market is anticipated to reach $8.52
billion by 2029, growing at a CAGR of 7.4% from 2022 to 2029.
Tissue diagnostics plays a pivotal role in
disease diagnosis, especially in cancer, utilizing advanced instruments such as
slide staining systems, slide scanners, tissue processing systems, embedding
systems, and tissue microarrays. This crucial study is conducted in hospitals,
reference laboratories, research institutes, pharmaceutical companies, and
contract research organizations.
The growth of the Tissue Diagnostics Market
is primarily attributed to the global increase in cancer prevalence, the
availability of biomarkers for cancer diagnosis and therapy, cancer screening
programs, a surge in clinical trials for cancer drugs, advanced tissue-based
companion diagnostic tests, and the growing global geriatric population.
Additionally, the rising focus on personalized healthcare, adoption of digital
pathology, automation in tissue diagnostics, and opportunities in emerging
economies contribute significantly to market expansion.
Here are the top 10 companies operating
in the Tissue Diagnostics Market: https://meticulousblog.org/top-10-companies-in-tissue-diagnostics-market/
F. Hoffmann-La Roche Ltd. (Switzerland):
Founded in 1896, F. Hoffmann-La Roche Ltd.
is a research-based healthcare company providing innovative medicines and
diagnostic solutions. The company operates globally through Pharmaceuticals and
Diagnostics segments.
Thermo Fisher Scientific Inc. (U.S.):
Established in 2006, Thermo Fisher
Scientific Inc. is a biotechnology company specializing in life sciences
research, patient diagnostics, and laboratory productivity. The company offers
diagnostic test kits, reagents, instruments, and associated products.
Abbott Laboratories (U.S.):
Founded in 1888, Abbott Laboratories is a
global healthcare company operating in diagnostics, medical devices, nutrition,
and branded generic pharmaceuticals markets. Abbott's Diagnostic segment offers
tissue diagnostics products through Molecular Diagnostics subsegment.
Danaher Corporation (U.S.):
Founded in 1969, Danaher Corporation
designs, manufactures, and markets medical, professional, industrial, and
commercial products. The company offers a range of products in the tissue
diagnostics market through its Diagnostics segment.
QIAGEN N.V. (Netherlands):
Established in 1984, QIAGEN N.V. is engaged
in the development and sales of instruments, consumables, and digital
bioinformatics solutions for various diagnostic applications. The company
operates through Molecular Diagnostics and Life Sciences segments.
Becton, Dickinson and Company (U.S.):
Founded in 1897, BD is a medical technology
company manufacturing and selling a wide range of medical devices, laboratory
equipment, and diagnostic products. The BD Life Sciences segment operates in
the tissue diagnostics market through the Biosciences category.
Abcam plc (U.K.):
Established in 1998, Abcam plc is involved
in the identification, development, and distribution of high-quality biological
reagents and tools used in scientific research, diagnostics, and drug
discovery.
Agilent Technologies (U.S.):
Incorporated in 1999, Agilent Technologies
provides application-focused solutions to the life sciences, diagnostics, and
applied chemical markets. The company offers tissue diagnostics through its
Diagnostics and Genomics segment.
Merck KGaA (Germany):
Founded in 1668, Merck is a science and
technology company operating through Healthcare, Life Sciences, and Electronics
segments. The Life Sciences segment offers a diverse range of products in the
tissue diagnostics market.
Sakura Finetek Japan Co., Ltd. (Japan):
Established in 2001, Sakura Finetek Japan
is a healthcare-based pathology automation company specializing in cancer
diagnosis. The company engages in the R&D, manufacture, sales, and
export/import of medical specimen preparation instruments, consumables,
reagents, and related products.
Top 10 Companies Leading the Tissue
Diagnostics Revolution: https://meticulousblog.org/top-10-companies-in-tissue-diagnostics-market/
Meticulous Research's latest report on the
Tissue Diagnostics Market predicts a growth rate of 7.4% during the forecast
period of 2022-2029.
For more detailed information on the
financial performance, key products, company strategies, partnerships, and
acquisitions of these companies, refer to Meticulous Research®'s latest report,
"Tissue Diagnostics Market – Global Opportunity Analysis and Industry
Forecast (2022-2029)."
The comprehensive report provides global
market size estimates, market share analysis, revenue numbers, and coverage of
key issues and trends in the Tissue Diagnostics Market.
For media inquiries or more information,
please contact:
Contact Us:
Meticulous Research®
Email- sales@meticulousresearch.com
Contact Sales- +1-646-781-8004
Connect with us on LinkedIn- https://www.linkedin.com/company/meticulous-research
Comments
Post a Comment